Which of the following nonsteroidal anti-inflammatory drugs (NSAIDs) is commercially available for parenteral administration to induce closure of the atrial opening in premature infants with patent ductus arteriosis? Select one: a. Ibuprofen b. Ketorolac c. Celecoxib d. None of the above